Category: Clinical Trials

  Why Is argenx Stock Rallying Today? Celiac Disease Drug Data Helps Shares Recover argenx stock is rebounding on October 9, 2026, after a s...

  Why Is Revolution Medicines Stock Falling? FDA Review Raises Questions Revolution Medicines (NASDAQ: RVMD) shares fell sharply on October ...

  Why Is Atrium Therapeutics Stock Surging Today? $50 Million Financing Boosts RNA Shares Atrium Therapeutics (NASDAQ: RNA) is in focus on O...

  Spyre Therapeutics Stock Falls After $350 Million Public Offering Spyre Therapeutics stock fell in after-hours trading after the clinical-...

  Genmab Shares Jump as Rina-S Shows Durable Ovarian Cancer Responses in Phase 2 Trial Genmab shares jumped more than 4% on Monday after the...

  Pyxis Oncology Stock Falls After Public Offering Announcement Shares of Pyxis Oncology (NASDAQ: PYXS) fell in after-hours trading on Sept...

  Dyne Therapeutics Stock Rises After Positive DM1 Trial Results Shares of Dyne Therapeutics (NASDAQ: DYN) moved higher in after-hours trad...

  Why Is Vanda Pharmaceuticals Stock Surging Today? VNDA Rally Explained Vanda Pharmaceuticals (NASDAQ: VNDA) is attracting strong buying i...

  AstraZeneca Seeks US FDA Approval for Lung Cancer Treatment With Tagrisso-Orpathys Combination AstraZeneca has submitted a New Drug Applic...

  MapLight Stock Falls 46% as InvestingPro Fair Value Flagged Overvaluation MapLight Therapeutics (NASDAQ: MPLT) has fallen sharply from its...